A Open-label Phase I Study to Evaluate Safety of a Sabin Inactivated Poliovirus Vaccine (sIPV) in Adults, Children, and Infants, and a Blinded, Randomized and Controlled Phase II to Evaluate Safety and Immunogenicity of it in Infants
Phase of Trial: Phase I/II
Latest Information Update: 29 Jul 2017
At a glance
- Drugs Poliovirus vaccine Intravacc/WHO (Primary) ; Poliovirus vaccine inactivated
- Indications Poliomyelitis
- Focus Pharmacodynamics
- Sponsors Sinovac Biotech
- 25 Jul 2017 Status changed from recruiting to completed.
- 01 May 2017 Planned primary completion date changed from 1 Jan 2017 to 1 Jun 2017.
- 12 Dec 2016 New trial record